Inflammation in juvenile idiopathic arthritis
- PMID: 17936170
- DOI: 10.1016/j.rdc.2007.07.004
Inflammation in juvenile idiopathic arthritis
Abstract
Inflammation in JIA results from the interaction of myeloid, lymphoid, and stromal cells, cartilage destruction, bone erosion, and debility. These cells and the mediators they release cause cartilage destruction, bone erosion, and debility. Neutrophils are thought to mediate much of the actual destruction within a joint; however, many cases of JIA are not associated with boney erosions, but there is significant inflammation caused by the cellular infiltrate and the proliferation of synoviocytes. NSAIDs address many of the non-cell-dependent aspects of inflammation. Disease-modifying drugs are required for resistant or progressive disease. These agents are effective in modifying the cellular interactions that perpetuate inflammation. In particular, TNFalpha inhibitors impair cell migration into the joint and reduce macrophage functions.
Republished from
-
Inflammation in juvenile idiopathic arthritis.Pediatr Clin North Am. 2005 Apr;52(2):335-57, v. doi: 10.1016/j.pcl.2005.01.002. Pediatr Clin North Am. 2005. PMID: 15820371 Review.
Similar articles
-
Cartilage oligomeric matrix protein in patients with juvenile idiopathic arthritis: relation to growth and disease activity.J Rheumatol. 2009 Aug;36(8):1749-54. doi: 10.3899/jrheum.080942. Epub 2009 Jul 15. J Rheumatol. 2009. PMID: 19605679
-
Juvenile idiopathic arthritis: a chronic pediatric musculoskeletal condition with significant orofacial manifestations.J Can Dent Assoc. 2008 Nov;74(9):813-21. J Can Dent Assoc. 2008. PMID: 19000466
-
Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis.J Immunol. 2009 Sep 15;183(6):3770-7. doi: 10.4049/jimmunol.0901637. Epub 2009 Aug 26. J Immunol. 2009. PMID: 19710474
-
Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.FEBS J. 2008 Sep;275(18):4448-55. doi: 10.1111/j.1742-4658.2008.06580.x. Epub 2008 Jul 24. FEBS J. 2008. PMID: 18662305 Review.
-
New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.Arch Dis Child Educ Pract Ed. 2009 Oct;94(5):144-50. doi: 10.1136/adc.2008.144576. Arch Dis Child Educ Pract Ed. 2009. PMID: 19770494 Review.
Cited by
-
Sex Differences in Mast Cell-Associated Disorders: A Life Span Perspective.Cold Spring Harb Perspect Biol. 2022 Oct 3;14(10):a039172. doi: 10.1101/cshperspect.a039172. Cold Spring Harb Perspect Biol. 2022. PMID: 35817512 Free PMC article. Review.
-
Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.BMC Musculoskelet Disord. 2015 Apr 30;16:103. doi: 10.1186/s12891-015-0555-9. BMC Musculoskelet Disord. 2015. PMID: 25925313 Free PMC article.
-
Development of a machine learning-based predictive nomogram for screening children with juvenile idiopathic arthritis: a pseudo-longitudinal study of 223,195 children in the United States.Front Public Health. 2025 May 29;13:1531764. doi: 10.3389/fpubh.2025.1531764. eCollection 2025. Front Public Health. 2025. PMID: 40510579 Free PMC article.
-
CBP/P300 Inhibition Impairs CD4+ T Cell Activation: Implications for Autoimmune Disorders.Biomedicines. 2024 Jun 18;12(6):1344. doi: 10.3390/biomedicines12061344. Biomedicines. 2024. PMID: 38927552 Free PMC article.
LinkOut - more resources
Full Text Sources